These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10759104)

  • 1. Physicians and drug company sales representatives.
    Davis GF
    Am J Med; 2000 Apr; 108(5):432-3. PubMed ID: 10759104
    [No Abstract]   [Full Text] [Related]  

  • 2. Encounters between physicians and pharmaceutical sales representatives.
    Yarnall SR
    Am J Med; 2000 Apr; 108(5):431-2. PubMed ID: 10759103
    [No Abstract]   [Full Text] [Related]  

  • 3. Need for better interactions between physicians and pharmaceutical sales representatives.
    Ferguson RP
    Ann Pharmacother; 2002 Dec; 36(12):1966-8. PubMed ID: 12494952
    [No Abstract]   [Full Text] [Related]  

  • 4. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
    Gaedeke RM; Tootelian DH; Sanders EE
    Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between family physicians and the pharmaceutical industry.
    Ostergaard DJ
    J Fam Pract; 1992 Jan; 34(1):29-31. PubMed ID: 1728650
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study.
    Anadaleeb SS; Tallman RF
    Health Mark Q; 1996; 13(4):79-89. PubMed ID: 10159647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Keep medical education independent! It should not be a scene of drug industry marketing].
    Eliasson G; Håkansson J
    Lakartidningen; 2001 Sep; 98(39):4168-9. PubMed ID: 11680148
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing the pharmaceutical industry-health system interface.
    Zarowitz BJ; Muma B; Coggan P; Davis G; Barkley GL
    Ann Pharmacother; 2001 Dec; 35(12):1661-8. PubMed ID: 11793639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hotel-based medicine.
    Greenwald R
    J Rheumatol; 2009 Feb; 36(2):456; author reply 456-7. PubMed ID: 19208583
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions between physicians and drug company representatives.
    Chren MM
    Am J Med; 1999 Aug; 107(2):182-3. PubMed ID: 10460053
    [No Abstract]   [Full Text] [Related]  

  • 12. What information do physicians receive from pharmaceutical representatives?
    Lexchin J
    Can Fam Physician; 1997 May; 43():941-5. PubMed ID: 9154366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuing medical education, physicians, and Pavlov: can we change what happens when industry rings the bell?
    Lichter PR
    Arch Ophthalmol; 2008 Nov; 126(11):1593-7. PubMed ID: 19001230
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States.
    Mintzes B; Lexchin J; Sutherland JM; Beaulieu MD; Wilkes MS; Durrieu G; Reynolds E
    J Gen Intern Med; 2013 Oct; 28(10):1368-75. PubMed ID: 23558775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep in the data mine. AMA sales of doc info lead to partnership questions.
    Conn J
    Mod Healthc; 2007 Jun; 37(23):8-9. PubMed ID: 17612000
    [No Abstract]   [Full Text] [Related]  

  • 16. Finding the line: physicians, pharma, and drug development.
    Redig A
    Acad Med; 2009 Feb; 84(2):228-9. PubMed ID: 19174673
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.
    Rosner F
    Mt Sinai J Med; 1995 Nov; 62(6):427-30. PubMed ID: 8692156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings.
    Barton L
    J Hosp Mark; 1993; 8(1):71-82. PubMed ID: 10135504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ties that bind? The web of CME and medical industry profit.
    Busby J
    Tex Med; 1991 Aug; 87(8):38-46. PubMed ID: 1925989
    [No Abstract]   [Full Text] [Related]  

  • 20. Physician-industry relations. Part 2: organizational issues.
    Coyle SL;
    Ann Intern Med; 2002 Mar; 136(5):403-6. PubMed ID: 11874315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.